Title: Amendment - 2nd Reading-yellow - Requested by: Barry Usher - (S) Committee of the Whole
Official Title: Amendment - 2nd Reading-yellow - Requested by: Barry Usher - (S) Committee of the Whole
Number of Sections: 1
Source: versions - HB0740.004.001_Amendments-in-Context_final-condensed(1).pdf
Media Type: application/pdf
Strikethrough Detection: 2 sections found

================================================================================

Section 1:
- 2025
69th Legislature 2025 Drafter: Julie Johnson, HB0740.004.001
1 HOUSE BILL NO. 740
2 INTRODUCED BY M. BERTOGLIO, M. THANE, Z. WIRTH
3
4 A BILL FOR AN ACT ENTITLED: “AN ACT GENERALLY REVISING LAWS RELATING TO PHARMACIES,
5 PHARMACY BENEFIT MANAGERS, AND OTHER ENTITIES; PROVIDING LAWS RELATING TO THE
6 RECOUPMENT OF FUNDS; PROVIDING DEFINITIONS; REVISING LAWS RELATED TO MAXIMUM
7 ALLOWABLE COST OR THE REFERENCE PRICE LIST; PROHIBITING CERTAIN FEES; EXEMPTING THE
8 GROUP HEALTH INSURANCE PLAN OF CERTAIN EMPLOYEES; AND AMENDING SECTIONS 33-2-2005,
9 33-22-170, 33-22-171, 33-22-172, 33-22-175, AND 33-22-177, AND 39-71-727, MCA; AND PROVIDING AN
10 APPLICABILITY SECTION AND A TERMINATION DATE.”
11
12 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MONTANA:
13
14 Section 1. Section 33-2-2005, MCA, is amended to read:
15 "33-2-2005. Prohibitions -- recoupment -- payment -- interest. An entity conducting an audit may
16 not:
17 (1) include dispensing fees unless a prescription was not actually dispensed, the prescriber denied
18 authorization, the prescription dispensed was a dispensing error by the pharmacy, or the identified
19 overpayment is based solely on an extra dispensing fee;
20 (2) recoup funds for prescription clerical or recordkeeping errors, including typographical errors,
21 scrivener's errors, and computer errors, in a required document or record unless the error results in actual
22 financial harm to the entity or to a consumer;
23 (3) collect any funds, charge-backs, or penalties until the audit and all appeals are final unless the
24 entity is alleging fraud or other intentional or willful misrepresentation that is evidenced by the review of claims
25 data, statements, physical review, or other investigative methods;
26 (4) use extrapolation or other statistical expansion techniques in calculating the amount of any
27 recoupment or penalty;
28 (5) pay the agent or employee who conducted the audit based on a percentage of the amount
- 1 - Authorized Print Version – HB 740
Amendment - 2nd Reading-yellow - Requested by: Barry Usher - (S) Committee of the Whole
- 2025
69th Legislature 2025 Drafter: Julie Johnson, HB0740.004.001
1 (3) The pharmacist may bill only for the cost of the generic-name product on a signed itemized
2 billing, except if purchase of the brand-name drug is allowed as provided in subsection (1).
3 (4) When billing for a brand-name drug, the pharmacist shall certify that the generic-name drug
4 was unavailable.
5 (5) The department shall establish a schedule of fees for prescription drugs.
6 (6) Except as provided in subsection (8), a pharmacist may not dispense more than a 30-day
7 supply at any one time.
8 (7) For purposes of this section, the terms "brand name" and "generic name" have the meanings
9 provided in 37-7-502.
10 (8) An insurer may not require a worker receiving benefits under this chapter to obtain medications
11 from an out-of-state mail service pharmacy. However, an insurer may authorize up to a 90-day supply of
12 medications from an in-state mail service pharmacy.
13 (9) The provisions of this section do not apply to an agreement between a preferred provider
14 organization and an insurer."
15
16 NEW SECTION. SECTION 7. APPLICABILITY. [THIS ACT] DOES NOT APPLY TO THE GROUP HEALTH
17 INSURANCE PLAN FOR STATE EMPLOYEES UNDER TITLE 2, CHAPTER 18, PART 7.
18
19 NEW SECTION. SECTION 7. APPLICABILITY. [THIS ACT] APPLIES TO CONDUCT OCCURRING ON OR AFTER
20 OCTOBER 1, 2025.
21
22 NEW SECTION. Section 8. Termination. [This act] terminates June 30, 2029.
23 - END -
- 10 - Authorized Print Version – HB 740
[DELETED:   D H-   H I  A P R A G 3 A  B  S " P n ( i a o ( r s f ( c e d ( u r ( p]
[DELETED:   D H-   ( T b ( W w ( T ( E s ( F p ( A f m ( T o  NS7. A.[T   PY HT  I     T2,1,7  NS7 A.[T PY HT  O1,2   N T -]


================================================================================

Raw Text:
Amendment - 2nd Reading-yellow - Requested by: Barry Usher - (S) Committee of the Whole
- 2025
69th Legislature 2025 Drafter: Julie Johnson, HB0740.004.001
1 HOUSE BILL NO. 740
2 INTRODUCED BY M. BERTOGLIO, M. THANE, Z. WIRTH
3
4 A BILL FOR AN ACT ENTITLED: “AN ACT GENERALLY REVISING LAWS RELATING TO PHARMACIES,
5 PHARMACY BENEFIT MANAGERS, AND OTHER ENTITIES; PROVIDING LAWS RELATING TO THE
6 RECOUPMENT OF FUNDS; PROVIDING DEFINITIONS; REVISING LAWS RELATED TO MAXIMUM
7 ALLOWABLE COST OR THE REFERENCE PRICE LIST; PROHIBITING CERTAIN FEES; EXEMPTING THE
8 GROUP HEALTH INSURANCE PLAN OF CERTAIN EMPLOYEES; AND AMENDING SECTIONS 33-2-2005,
9 33-22-170, 33-22-171, 33-22-172, 33-22-175, AND 33-22-177, AND 39-71-727, MCA; AND PROVIDING AN
10 APPLICABILITY SECTION AND A TERMINATION DATE.”
11
12 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MONTANA:
13
14 Section 1. Section 33-2-2005, MCA, is amended to read:
15 "33-2-2005. Prohibitions -- recoupment -- payment -- interest. An entity conducting an audit may
16 not:
17 (1) include dispensing fees unless a prescription was not actually dispensed, the prescriber denied
18 authorization, the prescription dispensed was a dispensing error by the pharmacy, or the identified
19 overpayment is based solely on an extra dispensing fee;
20 (2) recoup funds for prescription clerical or recordkeeping errors, including typographical errors,
21 scrivener's errors, and computer errors, in a required document or record unless the error results in actual
22 financial harm to the entity or to a consumer;
23 (3) collect any funds, charge-backs, or penalties until the audit and all appeals are final unless the
24 entity is alleging fraud or other intentional or willful misrepresentation that is evidenced by the review of claims
25 data, statements, physical review, or other investigative methods;
26 (4) use extrapolation or other statistical expansion techniques in calculating the amount of any
27 recoupment or penalty;
28 (5) pay the agent or employee who conducted the audit based on a percentage of the amount
- 1 - Authorized Print Version – HB 740

Amendment - 2nd Reading-yellow - Requested by: Barry Usher - (S) Committee of the Whole
- 2025
69th Legislature 2025 Drafter: Julie Johnson, HB0740.004.001
1 (3) The pharmacist may bill only for the cost of the generic-name product on a signed itemized
2 billing, except if purchase of the brand-name drug is allowed as provided in subsection (1).
3 (4) When billing for a brand-name drug, the pharmacist shall certify that the generic-name drug
4 was unavailable.
5 (5) The department shall establish a schedule of fees for prescription drugs.
6 (6) Except as provided in subsection (8), a pharmacist may not dispense more than a 30-day
7 supply at any one time.
8 (7) For purposes of this section, the terms "brand name" and "generic name" have the meanings
9 provided in 37-7-502.
10 (8) An insurer may not require a worker receiving benefits under this chapter to obtain medications
11 from an out-of-state mail service pharmacy. However, an insurer may authorize up to a 90-day supply of
12 medications from an in-state mail service pharmacy.
13 (9) The provisions of this section do not apply to an agreement between a preferred provider
14 organization and an insurer."
15
16 NEW SECTION. SECTION 7. APPLICABILITY. [THIS ACT] DOES NOT APPLY TO THE GROUP HEALTH
17 INSURANCE PLAN FOR STATE EMPLOYEES UNDER TITLE 2, CHAPTER 18, PART 7.
18
19 NEW SECTION. SECTION 7. APPLICABILITY. [THIS ACT] APPLIES TO CONDUCT OCCURRING ON OR AFTER
20 OCTOBER 1, 2025.
21
22 NEW SECTION. Section 8. Termination. [This act] terminates June 30, 2029.
23 - END -
- 10 - Authorized Print Version – HB 740

[DELETED:   D H-   H I  A P R A G 3 A  B  S " P n ( i a o ( r s f ( c e d ( u r ( p]
[DELETED:   D H-   ( T b ( W w ( T ( E s ( F p ( A f m ( T o  NS7. A.[T   PY HT  I     T2,1,7  NS7 A.[T PY HT  O1,2   N T -]